Zobrazeno 1 - 10
of 98
pro vyhledávání: '"Avi Leader"'
Publikováno v:
Cancer Medicine, Vol 13, Iss 15, Pp n/a-n/a (2024)
Abstract Chemotherapy‐induced thrombocytopenia (CIT) is a common challenge of cancer therapy and can lead to chemotherapy dose reduction, delay, and/or discontinuation, affecting relative dose intensity, and possibly adversely impacting cancer care
Externí odkaz:
https://doaj.org/article/b0417016656d4eadabb3ef2b20d98415
Publikováno v:
HemaSphere, Vol 7, p e95758de (2023)
Externí odkaz:
https://doaj.org/article/042308bab93744f988b83793c5110d87
Publikováno v:
Platelets, Vol 33, Iss 5, Pp 781-786 (2022)
As the immune thrombocytopenia exacerbation rate after booster COVID-19 vaccines is unknown, we explore the rates after first, second and booster Pfizer-BioNTech COVID-19 vaccines. A retrospective study of adult ITP patients, receiving 1–3 vaccines
Externí odkaz:
https://doaj.org/article/66b725912d0549a7a6fbd4cc92a64bc9
Autor:
Anna Falanga, Avi Leader, Chiara Ambaglio, Zsuzsa Bagoly, Giancarlo Castaman, Ismail Elalamy, Ramon Lecumberri, Alexander Niessner, Ingrid Pabinger, Sebastian Szmit, Alice Trinchero, Hugo Ten Cate, Bianca Rocca
Publikováno v:
HemaSphere, Vol 6, Iss 8, p e750 (2022)
In cancer patients, thrombocytopenia can result from bone marrow infiltration or from anticancer medications and represents an important limitation for the use of antithrombotic treatments, including anticoagulant, antiplatelet, and fibrinolytic agen
Externí odkaz:
https://doaj.org/article/a67b2595f54e423db652b8f6704f1a05
Autor:
Sarah Sharman Moser, Galia Spectre, Pia Raanani, Orr Friedman‐Mazursky, Matanya Tirosh, Gabriel Chodick, Avi Leader
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 6, Iss 4, Pp n/a-n/a (2022)
Abstract Background Recent international guidelines recommend thromboprophylaxis in patients with cancer at intermediate‐high venous thromboembolism (VTE) risk. Objectives We aimed to assess the current incidence, risk factors and management of can
Externí odkaz:
https://doaj.org/article/f92a4c4a9bad4369b802dfcc4a45ede7
Autor:
Ronit Gurion, Anat Gafter-Gvili, Liat Vidal, Avi Leader, Ron Ram, Adi Shacham-Abulafia, Mical Paul, Isaac Ben-Bassat, Ofer Shpilberg, Pia Raanani
Publikováno v:
Haematologica, Vol 98, Iss 1 (2013)
Second generation tyrosine kinase inhibitors have recently been introduced as first-line treatment for chronic phase chronic myelogenous leukemia. We aimed to evaluate the efficacy and safety of 2nd generation tyrosine kinase inhibitors versus imatin
Externí odkaz:
https://doaj.org/article/973edf2b8b3a4e84bf79b509b34878be
Autor:
Jonathan Naftali, Rani Barnea, Ruth Eliahou, Assaf Tolkovsky, Keshet Pardo, Michal Zukerman, Noa Soback, Meital Adi, Avi Leader, Sivan Bloch, Walid Saliba, Eitan Auriel
Publikováno v:
Acta Neurologica Scandinavica. 2023:1-7
Background. Cerebral microinfarcts (CMI) represent covert brain ischemia and were associated with stroke risk and cognitive impairment. Magnetic resonance imaging diffusion-weighted imaging (DWI) hyperintensities have been suggested to represent acut
Autor:
Renana Robinson, Galia Spectre, Michael Lishner, Ofek Sharabi, Eyal Robinson, Orly Hamburger Avnery, Anat Gafter-Gvili, Pia Raanani, Avi Leader
Publikováno v:
Journal of Thrombosis and Thrombolysis. 55:729-736
Autor:
Avi Leader, Sarah Elitzur, Baruch Gavrieli, Henri M.H. Spronk, Magdolna Nagy, Rene Van Oerle, Galia Spectre, Shai Shimony, Yakir Moshe, Roaya Mahajna, Gil Gilad, Galia Avrahami, Shai Izraeli, Pia Raanani, Shlomit Barzilai-Birenboim, Ofir Wolach
Publikováno v:
Blood. 140:1252-1254
Publikováno v:
Thrombosis Research. 213:S127-S132
This paper reviews the current evidence on the pathogenesis, clinical manifestations, diagnosis and management of cancer-associated non-bacterial thrombotic endocarditis (NBTE). NBTE is an underdiagnosed condition characterized by sterile valvular ve